Publications by authors named "T Maj"

Claim this Profile
I
Integrative and deep learning-based prediction of therapy response in ovarian cancer.
Alicja Rajtak, Ilona Skrabalak, Natalia Ćwilichowska-Puślecka, Agnieszka Kwiatkowska-Makuch, Marcin Poręba, Tomasz Maj

J Exp Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition.
Naisheng Zheng, Fuli Li, Qing Huang, Xian Huang, Tomasz Maj

Redox Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes can impact cellular immunity in solid tumors.
Malgorzata A Garstka, Lukasz Kedzierski, Tomasz Maj

Trends Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of multi-tyrosine kinase inhibitor ESK981 in combination with PD-1 inhibitor nivolumab in patients with metastatic castration-resistant prostate cancer.
Elisabeth I Heath, Wei Chen, Jae E Choi, Kimberlee Dobson, Melanie Smith, Tomasz Maj

Invest New Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of multi-kinase inhibitor ESK981 in patients with metastatic castration-resistant prostate cancer.
Elisabeth I Heath, Wei Chen, Lance Heilbrun, Jae E Choi, Kimberlee Dobson, Tomasz Maj

Invest New Drugs· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis